Enzymotec Files Registration Statement For Proposed Secondary Offering
2/13/2014 9:33:09 AM
MIGDAL HA'EMEQ, Israel, Feb. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has filed a registration statement on Form F-1 with the Securities and Exchange Commission for a proposed secondary public offering of 4,000,000 of its ordinary shares. The underwriters will have a 30-day option from the date of the offering to purchase up to an additional 600,000 ordinary shares. All of the shares will be offered by the Company's shareholders. The Company will not receive any proceeds from the sale of these shares.
Help employers find you! Check out all the jobs and post your resume.
comments powered by